UA111364C2 - Pharmaceutical composition for treating dependency in human beings - Google Patents

Pharmaceutical composition for treating dependency in human beings

Info

Publication number
UA111364C2
UA111364C2 UAA201400601A UAA201400601A UA111364C2 UA 111364 C2 UA111364 C2 UA 111364C2 UA A201400601 A UAA201400601 A UA A201400601A UA A201400601 A UAA201400601 A UA A201400601A UA 111364 C2 UA111364 C2 UA 111364C2
Authority
UA
Ukraine
Prior art keywords
pharmaceutical composition
human beings
dependency
treating
treating dependency
Prior art date
Application number
UAA201400601A
Other languages
Ukrainian (uk)
Inventor
Філіп Бернар
Фабріс Троверо
Original Assignee
Грінфарма
Ке Обс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Грінфарма, Ке Обс filed Critical Грінфарма
Publication of UA111364C2 publication Critical patent/UA111364C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Abstract

Винахід стосується фармацевтичної композиції для лікування фізичної залежності людей, що складається з двох активних інгредієнтів:- сполуки, що має антагоністичну активність щодо 5-НТ2 рецепторів серотоніну, яка вибрана з ципрогептадину і- сполуки, що має антагоністичну активність щодо альфа-1-норадренергічних рецепторів, вибрана з групи, що складається з празозину, альфузозину, теразозину, тамсулозину, силодозину і доксазозину. Винахід також стосується фармацевтичного продукту.The invention relates to a pharmaceutical composition for the treatment of physical dependence of humans, consisting of two active ingredients: a compound having antagonistic activity against 5-HT2 serotonin receptors selected from cyproheptadine and selected from the group consisting of prazosin, alfuzosin, terazosin, tamsulosin, silodosin and doxazosin. The invention also relates to a pharmaceutical product.

UAA201400601A 2011-06-24 2012-06-25 Pharmaceutical composition for treating dependency in human beings UA111364C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1155631A FR2976807B1 (en) 2011-06-24 2011-06-24 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DEPENDENCE IN HUMAN BEINGS
PCT/FR2012/051443 WO2012175894A1 (en) 2011-06-24 2012-06-25 Pharmaceutical composition for treating dependency in human beings

Publications (1)

Publication Number Publication Date
UA111364C2 true UA111364C2 (en) 2016-04-25

Family

ID=46579182

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201400601A UA111364C2 (en) 2011-06-24 2012-06-25 Pharmaceutical composition for treating dependency in human beings

Country Status (4)

Country Link
FR (1) FR2976807B1 (en)
RU (1) RU2605283C2 (en)
UA (1) UA111364C2 (en)
WO (1) WO2012175894A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3017296A1 (en) * 2013-11-28 2015-08-14 Greenpharma Sas PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DEPENDENCE IN HUMAN BEINGS
FR3138303A1 (en) * 2022-07-26 2024-02-02 Kinnov Therapeutics PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF POST-TRAUMATIC STRESS SYNDROME

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2190392C1 (en) * 2001-09-14 2002-10-10 Нестерук Владимир Викторович Doxazozine-based pharmaceutical composition
FR2873294B1 (en) 2004-07-26 2008-05-09 Greenpharma Sa Sa ASSOCIATION OF DRUGS
CA2575995A1 (en) * 2004-08-13 2006-02-16 Omeros Corporation Treatment for methamphetamine addiction and reduction of methamphetamine use using serotonin antagonists
FR2954699B1 (en) * 2009-12-30 2012-01-20 Greenpharma Sas PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALCOHOL DEPENDENCE

Also Published As

Publication number Publication date
FR2976807A1 (en) 2012-12-28
RU2605283C2 (en) 2016-12-20
FR2976807B1 (en) 2013-07-05
RU2014101958A (en) 2015-07-27
WO2012175894A1 (en) 2012-12-27

Similar Documents

Publication Publication Date Title
ZA202202711B (en) Sustained-release dosage forms of ruxolitinib
CY1124311T1 (en) DNA-PK INHIBITORS
EA201400772A1 (en) OPTIONS OF PH20 POLYPEPTIDES, COMPOSITIONS ON THEIR BASIS AND THEIR APPLICATION
SA518391170B1 (en) Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology
EA201390060A1 (en) ANNELED PYRIMIDINES AND TRIAZINES AND THEIR APPLICATION FOR THE TREATMENT AND / OR PREVENTION OF CARDIOVASCULAR DISEASES
EA201291336A1 (en) SUBSTITUTED 5-FLUOR-1H-PYRAZOLOPIRIDINE AND THEIR APPLICATION
EA201590987A1 (en) CONNECTIONS AND METHODS OF THEIR APPLICATION
EA201491339A1 (en) SUBSTITUTED ANNELLATED PYRIMIDINES AND TRIAZINES AND THEIR APPLICATION
EA201290836A1 (en) RELATED BIS-ARYL ARYLTRIAZOLONES AND THEIR APPLICATION
EA201300987A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING METHORMENE AND DPP-4 INHIBITOR OR SGLT-2 INHIBITOR
EA201390203A1 (en) METHODS OF OBTAINING TUBULIZINS
EA201391644A1 (en) PARTIALLY SATURATED TRICYCLIC COMPOUNDS AND METHODS FOR THEIR RECEPTION AND APPLICATION
EA201490423A1 (en) METHODS AND COMPOSITIONS RELATED TO p62 FOR TREATMENT AND PREVENTION OF CANCER
EA202090183A1 (en) COMPOSITIONS, METHODS AND OBTAINING DEUTERED DOMPERIDONE
MX2014008706A (en) Tricyclic sulfonamide compounds and methods of making and using same.
CL2023002345A1 (en) Compositions and methods for manufacturing protein microparticles.
EA201490037A1 (en) ANTAGONISTS TRPV4
MX2018001733A (en) Fumagillol heterocyclic compounds and methods of making and using same.
EA201400623A1 (en) NEW 2H-INDASOLS AS ANTAGONISTS EP EPCEPTOR
EA201690039A1 (en) RORC2 INHIBITORS AND METHODS OF THEIR APPLICATION
CY1116234T1 (en) Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2 / 3 conformers
EA201791009A1 (en) COMPOSITIONS CONTAINING CYCLOSPORIN
EA201591507A1 (en) TREATMENT OF MULTIPLE SCLEROSIS BY LACHINIMODOM
EA201790699A1 (en) STABILIZED DERIVATIVES OF ADRENOMEDULLINE AND THEIR APPLICATION
MX2018014129A (en) Pharmaceutical composition comprising eteplirsen.